October 21, 2008FDA Is Faulted for Oversight of Foreign Drugs - Wall Street Journal FDA Is Faulted for Oversight of Foreign Drugs - Wall Street Journal
WASHINGTON -- The Food and Drug Administration is failing to keep accurate data about foreign drug facilities it is supposed to oversee and often doesn't follow up warning letters with inspections, according to a report by the investigative arm of Source: online.wsj.com UPDATE 2-US FDA extends review of Pfizer osteoporosis drug - Reuters WASHINGTON, Oct 21 (Reuters) - U.S. regulators have extended by three months their review of a proposed osteoporosis drug from Pfizer Inc (PFE.N: Quote , Profile , Research , Stock Buzz ) to study the pill in more depth, a company spokeswoman said on Source: www.reuters.com US panel backs Genzyme's new version of Myozyme - Boston Globe WASHINGTON - Genzyme Corp.'s new version of the drug Myozyme should be approved, a US panel said yesterday, even though Food and Drug Administration reviewers reported it may trigger allergic reactions and may not be effective. The panel of FDA Source: www.boston.com Petition calls for FDA to regulate energy drinks - AZCentral.com One hundred scientists and physicians have written a letter to the Food and Drug Administration asking for more regulation of increasingly popular energy drinks because their high caffeine content puts young drinkers at possible risk for caffeine Source: www.azcentral.com Dynavax and Merck & Co., Inc. Provide Update on U.S. FDA Clinical Hold - MSN MoneyCentral Dynavax Technologies Corporation DVAX and Merck & Co., Inc. have received communication from the U.S. Food and Drug Administration (FDA) regarding the two companies' response to the agency's request for safety information relating to the clinical Source: news.moneycentral.msn.com # posted by Network @ 10:00 PM
 |
Subscribe to Posts [Atom]